2007 Guidelines for the Management of Arterial Hypertension

Cockroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580

Hallan, 2004, Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay, Am J Kidney Dis, 44, 84, 10.1053/j.ajkd.2004.03.027

Morgan, 2004, Effect of different antihypertensive drug classes on central aortic pressure, Am J Hypertens, 17, 118, 10.1016/j.amjhyper.2003.09.012

Chen, 1997, Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function, Circulation, 95, 1827, 10.1161/01.CIR.95.7.1827

Hope, 2003, Use of arterial transfer functions for the derivation of aortic waveform characteristics, J Hypertens, 21, 1299, 10.1097/00004872-200307000-00017

Korsgaard, 1993, Histology of subcutaneous small arteries from patients with essential hypertension, Hypertension, 22, 523, 10.1161/01.HYP.22.4.523

Rizzoni, 2001, Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus, Circulation, 103, 1238, 10.1161/01.CIR.103.9.1238

Rizzoni, 2003, Prognostic significance of small-artery structure in hypertension, Circulation, 108, 2230, 10.1161/01.CIR.0000095031.51492.C5

Stevens, 2006, Assessing kidney function–measured and estimated glomerular filtration rate, N Engl J Med, 354, 2473, 10.1056/NEJMra054415

Martinez-Perez, 2002, Retinal vascular tree morphology: a semi-automatic quantification, IEEE Trans Biomed Eng, 49, 912, 10.1109/TBME.2002.800789

Hughes, 2006, Quantification of topological changes in retinal vascular architecture in essential and malignant hypertension, J Hypertens, 24, 889, 10.1097/01.hjh.0000222759.61735.98

Ciulla, 2002, Assessment of carotid plaque composition in hypertensive patients by ultrasonic tissue characterization: a validation study, J Hypertens, 20, 1589, 10.1097/00004872-200208000-00022

De Zeeuw, 2006, Renoprotective effects of renin-angiotensin-system inhibitors, Lancet, 367, 899, 10.1016/S0140-6736(06)68374-8

Mann, 2006, Renoprotective effects of renin-angiotensin-system inhibitors, Lancet, 367, 900, 10.1016/S0140-6736(06)68375-X

Haynes, 2002, Helping patients follow prescribed treatment: clinical applications, JAMA, 288, 2880, 10.1001/jama.288.22.2880

Groppelli, 1992, Persistent blood pressure increase induced by heavy smoking, J Hypertens, 10, 495, 10.1097/00004872-199205000-00014

Grassi, 1994, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans, Circulation, 90, 248, 10.1161/01.CIR.90.1.248

Narkiewicz, 1998, Cigarette smoking increases sympathetic outflow in humans, Circulation, 98, 528, 10.1161/01.CIR.98.6.528

Seltzer, 1974, Effect of smoking on blood pressure, Am Heart J, 87, 558, 10.1016/0002-8703(74)90492-X

Bang, 2000, Do we undertreat hypertensive smokers? A comparison between smoking and non-smoking hypertensives, Blood Press Monit, 5, 271, 10.1097/00126097-200010000-00004

Manson, 1992, The primary prevention of myocardial infarction, N Engl J Med, 326, 1406, 10.1056/NEJM199205213262107

Grassi, 2002, Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension, Circulation, 106, 1957, 10.1161/01.CIR.0000033519.45615.C7

Grassi, 1997, Baroreflex impairment by low sodium diet in mild or moderate essential hypertension, Hypertension, 29, 802, 10.1161/01.HYP.29.3.802

Pilz, 2005, Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats, Hypertension, 46, 569, 10.1161/01.HYP.0000179573.91016.3f

Parati, 1998, The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension, J Hypertens, 16, 1685, 10.1097/00004872-199816110-00016

Yusuf, 2003, Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial, Lancet, 362, 777, 10.1016/S0140-6736(03)14285-7

Perera, 1955, Hypertensive vascular disease: description and natural history, J Chronic Dis, 1, 33, 10.1016/0021-9681(55)90019-9

Giannattasio, 1999, Fluctuations of radial artery distensibility throughout the menstrual cycle, Arterioscler Thromb Vasc Biol, 19, 1925, 10.1161/01.ATV.19.8.1925

Ribstein, 1999, Renal characteristics and effect of angiotensin suppression in oral contraceptive users., Hypertension, 33, 90, 10.1161/01.HYP.33.1.90

Perry, 1990, Recording diastolic blood pressure in pregnancy, Br Med J, 301, 1198, 10.1136/bmj.301.6762.1198

Higgins, 2001, Blood pressure measurement and classification in pregnancy, Lancet, 357, 131, 10.1016/S0140-6736(00)03552-2

Bakris, 2006, Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome, Diabetes Care, 29, 2592, 10.2337/dc06-1373

Schupp, 2004, Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity, Circulation, 109, 2054, 10.1161/01.CIR.0000127955.36250.65